Cardiovascular disease risk in patients with and without metabolic dysfunction-associated steatotic liver disease: A clinical and subclinical evaluation.

Omar MYAY, El-Mallah AME, Bakr MGMA, Ragab MME.

Open source

DOI
10.1016/j.ahjo.2026.100865
Published
2026-08-29
Container
Am Heart J Plus
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ahjo.2026.100865,
  title = {Cardiovascular disease risk in patients with and without metabolic dysfunction-associated steatotic liver disease: A clinical and subclinical evaluation.},
  author = {Omar MYAY and  El-Mallah AME and  Bakr MGMA and  Ragab MME.},
  year = {2026},
  journal = {Am Heart J Plus},
  doi = {10.1016/j.ahjo.2026.100865},
  url = {https://doi.org/10.1016/j.ahjo.2026.100865}
}

RIS

TY  - JOUR
TI  - Cardiovascular disease risk in patients with and without metabolic dysfunction-associated steatotic liver disease: A clinical and subclinical evaluation.
AU  - Omar MYAY
AU  -  El-Mallah AME
AU  -  Bakr MGMA
AU  -  Ragab MME.
PY  - 2026
JO  - Am Heart J Plus
DO  - 10.1016/j.ahjo.2026.100865
UR  - https://doi.org/10.1016/j.ahjo.2026.100865
ER  - 

APA

MYAY, O., AME, E., MGMA, B., & MME., R. (2026). Cardiovascular disease risk in patients with and without metabolic dysfunction-associated steatotic liver disease: A clinical and subclinical evaluation.. Am Heart J Plus. https://doi.org/10.1016/j.ahjo.2026.100865

Source records